Sep 5, 2018
This week's View summarizes the ARRIVE (Aspirin to Reduce Risk of Initial Vascular Events) and GLOBAL LEADERS trials and an article about the variability of left ventricular (LV) ejection fraction measured by different imaging modalities in patients with LV dysfunction.